Corrigendum: A Personalized Approach to Treatment: Use of EGFR Tyrosine Kinase Inhibitors for the Treatment of Non-Small-Cell Lung Cancer in Canada

Current Oncology - Canada
doi 10.3747/co.19.1150
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

MultiMed Inc.